Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_assertion type Assertion NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_head.
- NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_assertion description "[The enrichment of ERBB2 mutations/fusion in CDH1-mutated ILC (5 of 22, 23%) compared with the 5 ERBB2 mutations in a series of 286 non-CDH1-mutated breast cancers from which the ILC cases were obtained (5 of 286, 2%) was significant (P = 0.0006).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_provenance.
- NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_assertion evidence source_evidence_literature NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_provenance.
- NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_assertion SIO_000772 23575477 NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_provenance.
- NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_assertion wasDerivedFrom befree-20140225 NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_provenance.
- NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_assertion wasGeneratedBy ECO_0000203 NP767701.RAmWkd8jytl-okpF4J_jTfj_q2k0rcEW-Ttvm8g6yE5VI130_provenance.